The U.S. FDA cleared 20 drugs in October 2025, up from 17 in September, 18 in August and 17 in July, bringing the year’s total to 181 approvals through the first 10 months. Two new molecular entities ...

Revir Therapeutics Inc. has announced progress in its HTT-PMS1 genetic medicine program for Huntington’s disease with the ...

It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of ...

GE Healthcare Technologies Inc. agreed to purchase medical imaging company Intelerad Medical Systems Inc. for $2.3 billion in ...

With phase I/II data in hand, Taiho Pharmaceutical Co. Ltd. and Cullinan Therapeutics Inc. began filing a rolling NDA to the ...

The Scottish government has published a strategy setting out a roadmap to more than double the size of Scotland’s life sciences sector over the next 10 years. The most recent data show the sector ...

Contineum Therapeutics Inc.’s midstage study of its multiple sclerosis drug, PIPE-307, missed its primary and secondary endpoints, dropping the stock on Nov. 21. Top-line phase II results from the ...

Abbott Laboratories made plans to enter the cancer screening market with its reported acquisition of Exact Sciences Corp. The ...

Archeon Medical SAS reported data from a study showing its real-time ventilation feedback device Eolife increased the ...

U.S. and European organ-on-a-chip specialty biotechnology companies are driving development of organ-on-a-chip technologies, ...

Solventum Corp. continued its restructuring with a second significant acquisition this year, the proposed purchase of ...

Scineuro Pharmaceuticals Holdings Ltd. has received a $5 million research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to accelerate the preclinical development of the ...